目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GENOME EDITING MARKET, BY TECHNOLOGY
6.1. Overview
6.2. Meganucleases
6.3. (CRISPR)/Cas9
6.4. TALENs/MegaTALs
6.5. ZFN
6.6. Others

7. GENOME EDITING MARKET, BY DELIVERY METHOD
7.1. Overview
7.2. Ex-vivo
7.3. In-vivo

8. GENOME EDITING MARKET, BY MODE
8.1. Overview
8.2. Contract
8.3. In-house

9. GENOME EDITING MARKET, BY END-USE
9.1. Overview
9.2. Biotechnology & Pharmaceutical Companies
9.3. Academic & Government Research Institutes
9.4. Contract Research Organizations

10. GENOME EDITING MARKET, BY APPLICATION
10.1. Overview
10.2. Genetic Engineering
10.3. Cell Line Engineering
10.4. Animal Genetic Engineering
10.5. Plant Genetic Engineering
10.6. Others

11. GENOME EDITING MARKET, BY CLINICAL APPLICATIONS
11.1. Overview
11.2. Diagnostics
11.3. Therapy Development

12. GENOME EDITING MARKET, BY REGION
12.1. Overview
12.1. North America
12.1.1. US
12.1.2. Canada
12.2. Europe
12.2.1. Germany
12.2.2. France
12.2.3. UK
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Asia-Pacific
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. South Korea
12.3.5. Australia
12.3.6. Rest of Asia-Pacific
12.4. Rest of the World
12.4.1. Middle East
12.4.2. Africa
12.4.3. Latin America

13. COMPETITIVE LANDSCAPE
13.1. Overview
13.2. Competitive Analysis
13.3. Market Share Analysis
13.4. Major Growth Strategy in the Genome editing Market,
13.5. Competitive Benchmarking
13.6. Leading Players in Terms of Number of Developments in the Genome editing Market,
13.7. Key developments and Growth Strategies
13.7.1. New Product Launch/Service Deployment
13.7.2. Merger & Acquisitions
13.7.3. Joint Ventures
13.8. Major Players Financial Matrix
13.8.1. Sales & Operating Income, 2022
13.8.2. Major Players R&D Expenditure. 2022

14. COMPANY PROFILES
14.1. Merck KGaA
14.1.1. Company Overview
14.1.2. Financial Overview
14.1.3. Products Offered
14.1.4. Key Developments
14.1.5. SWOT Analysis
14.1.6. Key Strategies
14.2. Cibus
14.2.1. Company Overview
14.2.2. Financial Overview
14.2.3. Products Offered
14.2.4. Key Developments
14.2.5. SWOT Analysis
14.2.6. Key Strategies
14.3. Recombinetics, Inc.
14.3.1. Company Overview
14.3.2. Financial Overview
14.3.3. Products Offered
14.3.4. Key Developments
14.3.5. SWOT Analysis
14.3.6. Key Strategies
14.4. Sangamo
14.4.1. Company Overview
14.4.2. Financial Overview
14.4.3. Products Offered
14.4.4. Key Developments
14.4.5. SWOT Analysis
14.4.6. Key Strategies
14.5. Editas Medicine
14.5.1. Company Overview
14.5.2. Financial Overview
14.5.3. Products Offered
14.5.4. Key Developments
14.5.5. SWOT Analysis
14.5.6. Key Strategies
14.6. Precision Biosciences
14.6.1. Company Overview
14.6.2. Financial Overview
14.6.3. Products Offered
14.6.4. Key Developments
14.6.5. SWOT Analysis
14.6.6. Key Strategies
14.7. CRISPR Therapeutics
14.7.1. Company Overview
14.7.2. Financial Overview
14.7.3. Products Offered
14.7.4. Key Developments
14.7.5. SWOT Analysis
14.7.6. Key Strategies
14.8. Intellia Therapeutics, Inc.
14.8.1. Company Overview
14.8.2. Financial Overview
14.8.3. Products Offered
14.8.4. Key Developments
14.8.5. SWOT Analysis
14.8.6. Key Strategies
14.9. CARIBOU BIOSCIENCES, INC.
14.9.1. Company Overview
14.9.2. Financial Overview
14.9.3. Products Offered
14.9.4. Key Developments
14.9.5. SWOT Analysis
14.9.6. Key Strategies
14.10. Cellectis S.A.
14.10.1. Company Overview
14.10.2. Financial Overview
14.10.3. Products Offered
14.10.4. Key Developments
14.10.5. SWOT Analysis
14.10.6. Key Strategies
14.11. AstraZeneca
14.11.1. Company Overview
14.11.2. Financial Overview
14.11.3. Products Offered
14.11.4. Key Developments
14.11.5. SWOT Analysis
14.11.6. Key Strategies
14.12. Takara Bio USA
14.12.1. Company Overview
14.12.2. Financial Overview
14.12.3. Products Offered
14.12.4. Key Developments
14.12.5. SWOT Analysis
14.12.6. Key Strategies
14.13. Horizon Discovery Group plc
14.13.1. Company Overview
14.13.2. Financial Overview
14.13.3. Products Offered
14.13.4. Key Developments
14.13.5. SWOT Analysis
14.13.6. Key Strategies

15. APPENDIX
15.1. References
15.2. Related Reports

LIST OF TABLES
TABLE 1 GENOME EDITING MARKET, SYNOPSIS, 2018-2032
TABLE 2 GENOME EDITING MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 4 GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 5 GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 6 GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 7 GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 GENOME EDITING MARKET, BY CLINICAL APPLICATIONS , 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 12 NORTH AMERICA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 13 NORTH AMERICA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 NORTH AMERICA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 15 US: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 16 US: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 17 US: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 18 US: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 19 US: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 US: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 21 CANADA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 22 CANADA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 23 CANADA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 24 CANADA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 25 CANADA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 26 CANADA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 2 EUROPE: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 3 EUROPE: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 4 EUROPE: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 5 EUROPE: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 EUROPE: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 7 GERMANY: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 8 GERMANY: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 9 GERMANY: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 10 GERMANY: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 11 GERMANY: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 GERMANY: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 13 FRANCE: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 14 FRANCE: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 15 FRANCE: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 16 FRANCE: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 17 FRANCE: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 FRANCE: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 19 ITALY: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 20 ITALY: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 21 ITALY: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 22 ITALY: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 23 ITALY: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 24 ITALY: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 25 SPAIN: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 26 SPAIN: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 27 SPAIN: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 28 SPAIN: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 29 SPAIN: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 30 SPAIN: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 31 UK: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 32 UK: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 33 UK: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 34 UK: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 35 UK: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 UK: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 37 REST OF EUROPE: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 38 REST OF EUROPE: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 39 REST OF EUROPE: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 40 REST OF EUROPE: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 41 REST OF EUROPE: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 42 REST OF EUROPE: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 43 ASIA-PACIFIC: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 44 ASIA-PACIFIC: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 45 ASIA-PACIFIC: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 46 ASIA-PACIFIC: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 47 ASIA-PACIFIC: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 ASIA-PACIFIC: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 49 JAPAN: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 50 JAPAN: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 51 JAPAN: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 52 JAPAN: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 53 JAPAN: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 54 JAPAN: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 55 CHINA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 56 CHINA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 57 CHINA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 58 CHINA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 59 CHINA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 60 CHINA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 61 INDIA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 62 INDIA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 63 INDIA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 64 INDIA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 65 INDIA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 66 INDIA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 67 AUSTRALIA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 68 AUSTRALIA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 69 AUSTRALIA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 70 AUSTRALIA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 71 AUSTRALIA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 AUSTRALIA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 73 SOUTH KOREA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 74 SOUTH KOREA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 75 SOUTH KOREA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 76 SOUTH KOREA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 77 SOUTH KOREA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 78 SOUTH KOREA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 79 REST OF ASIA-PACIFIC: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 80 REST OF ASIA-PACIFIC: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 81 REST OF ASIA-PACIFIC: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 82 REST OF ASIA-PACIFIC: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 83 REST OF ASIA-PACIFIC: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 84 REST OF ASIA-PACIFIC: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 85 REST OF THE WORLD: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 86 REST OF THE WORLD: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 87 REST OF THE WORLD: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 88 REST OF THE WORLD: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 89 REST OF THE WORLD: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 90 REST OF THE WORLD: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 91 MIDDLE EAST: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 92 MIDDLE EAST: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 93 MIDDLE EAST: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 94 MIDDLE EAST: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 95 MIDDLE EAST: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 96 MIDDLE EAST: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 97 AFRICA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 98 AFRICA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 99 AFRICA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 100 AFRICA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 101 AFRICA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 102 AFRICA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)
TABLE 103 LATIN AMERICA: GENOME EDITING MARKET, BY TECHNOLOGY , 2018-2032 (USD BILLION)
TABLE 104 LATIN AMERICA: GENOME EDITING MARKET, BY DELIVERY METHOD , 2018-2032 (USD BILLION)
TABLE 105 LATIN AMERICA: GENOME EDITING MARKET, BY MODE, 2018-2032 (USD BILLION)
TABLE 106 LATIN AMERICA: GENOME EDITING MARKET, BY END-USE , 2018-2032 (USD BILLION)
TABLE 107 LATIN AMERICA: GENOME EDITING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 108 LATIN AMERICA: GENOME EDITING MARKET, BY CLINICAL APPLICATIONS, 2018-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GENOME EDITING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GENOME EDITING MARKET
FIGURE 4 GENOME EDITING MARKET, SHARE (%), BY TECHNOLOGY , 2022
FIGURE 5 GENOME EDITING MARKET, SHARE (%), BY DELIVERY METHOD , 2022
FIGURE 6 GENOME EDITING MARKET, SHARE (%), BY MODE, 2022
FIGURE 7 GENOME EDITING MARKET, SHARE (%), BY END-USE , 2022
FIGURE 8 GENOME EDITING MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 9 GENOME EDITING MARKET, SHARE (%), BY CLINICAL APPLICATIONS, 2022
FIGURE 10 GENOME EDITING MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 NORTH AMERICA: GENOME EDITING MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 EUROPE: GENOME EDITING MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 ASIA-PACIFIC: GENOME EDITING MARKET, SHARE (%), BY REGION, 2022
FIGURE 14 REST OF THE WORLD: GENOME EDITING MARKET, SHARE (%), BY REGION, 2022
FIGURE 15 GENOME EDITING MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 16 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 MERCK KGAA: SWOT ANALYSIS
FIGURE 18 CIBUS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 CIBUS: SWOT ANALYSIS
FIGURE 20 RECOMBINETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 RECOMBINETICS, INC.: SWOT ANALYSIS
FIGURE 22 SANGAMO: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 SANGAMO: SWOT ANALYSIS
FIGURE 24 EDITAS MEDICINE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 EDITAS MEDICINE: SWOT ANALYSIS
FIGURE 26 PRECISION BIOSCIENCES.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PRECISION BIOSCIENCES.: SWOT ANALYSIS
FIGURE 28 CRISPR THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 CRISPR THERAPEUTICS: SWOT ANALYSIS
FIGURE 30 INTELLIA THERAPEUTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 INTELLIA THERAPEUTICS, INC.: SWOT ANALYSIS
FIGURE 32 CARIBOU BIOSCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 CARIBOU BIOSCIENCES, INC.: SWOT ANALYSIS
FIGURE 34 CELLECTIS S.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 CELLECTIS S.A.: SWOT ANALYSIS
FIGURE 36 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 ASTRAZENECA: SWOT ANALYSIS
FIGURE 38 TAKARA BIO USA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 TAKARA BIO USA: SWOT ANALYSIS
FIGURE 40 HORIZON DISCOVERY GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 HORIZON DISCOVERY GROUP PLC: SWOT ANALYSIS